MRI Interventions, developer of innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, reports that Veterans Affairs Medical Center (VAMC) in San Francisco, Calif., has become the first VA hospital to offer MRI-guided asleep deep brain stimulation (NYSE:DBS) surgery to veterans suffering from Parkinson's disease.
Dr. Paul Larson, chief of neurosurgery at the San Francisco VAMC in October, led the center's first asleep DBS procedure using MRIC's ClearPoint® Neuro Intervention System for real-time MRI guidance and visualization to plan, target, and confirm results of the surgery.
DBS therapy is an important treatment option for many patients with Parkinson's disease, and has the potential to significantly reduce symptoms with life-changing results. The therapy involves the delivery of electrical signals to specific locations within the brain to relieve some of the debilitating symptoms of Parkinson's disease.
The ClearPoint System navigation platform provides real-time, direct visualization during minimally invasive neurosurgical procedures, providing patients with the opportunity to rest under general anesthesia during the surgical procedure.
"I am happy to be able to extend the asleep DBS option to veterans struggling with Parkinson's disease," stated Dr. Larson. "Anatomical targeting with the ClearPoint System is very accurate and allows us to reach the desired location for electrode placement on the first pass in the vast majority of cases, without awake patient participation. The result is that our patients get to sleep through surgery, which can take away some of the anxiety leading up to a procedure."
The ClearPoint platform is the only technology that enables minimally invasive neurosurgery under continuous MRI guidance. This provides the surgeon with superior visualization of the brain's tissue, allowing them to see and select a neurological target, aim the ClearPoint targeting device at the target, and watch MRI as the surgical instrument is advanced to the target location inside the patient's brain.
For more information, visit mriinterventions.com
MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com